Managing Migraine through Ayurveda with the intake of Tablet Laghu Sutashekhar Rasa and Brihat Dashmoola Taila as Nasal drops

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2023
INTERVENTION: CONDITION: Health Condition 1: G439‐ Migraine, unspecified PRIMARY OUTCOME: Decrease in episodes of chief complaints of Migraine.Timepoint: 45 days SECONDARY OUTCOME: Improvement in quality of life.Timepoint: 45 days INCLUSION CRITERIA: 1. Patients in the age group 18 to 60 years, presenting with signs and symptoms of Migraine will be included in the study. 2. Chronicity of the disease up to 10 years. 3. The diagnosis of the disease shall be done on the basis of clinical manifestations like a recurrent attack of headache, mostly unilateral in site, variable in intensity, frequency, and duration with or without nausea, vomiting, aura, and GI tract symptoms.
Epistemonikos ID: 5e6855a148c73585956004986fe0ef8e9e2082e5
First added on: Feb 20, 2024